ArticleAmerican journal of translational research2025

Tirzepatide alleviates non-alcoholic fatty liver disease by regulating lipid metabolism through activation of the AMPK/NF-κB signaling pathway.

Pengfei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.